Mr. Trent Woloveck reports

JUSHI HOLDINGS INC. ANNOUNCES RECEIPT OF DEA REGISTRATIONS FOR STATE-LICENSED MEDICAL CANNABIS OPERATIONS

Jushi Holdings Inc. has received registrations from the U.S. Drug Enforcement Administration (DEA) for certain state-licensed medical marijuana operations as part of the initial issuance of federal registrations to qualifying medical marijuana businesses.

The registrations follow the Attorney General's April, 2026, order, which rescheduled qualifying state-licensed medical marijuana to Schedule III under the Controlled Substances Act and established a federal regulatory framework for eligible operators. The company previously announced the submission of its DEA registration applications on May 28, 2026.

"Receiving DEA registrations represents an important milestone for Jushi and the medical patients we serve," said Jim Cacioppo, chief executive officer of Jushi. "We appreciate the efforts of the Trump Administration and the DEA in advancing meaningful cannabis reform and recognizing state-licensed medical cannabis operators. We believe this marks an important step toward greater alignment between state and federal regulation and a more consistent regulatory framework for the industry."

About Jushi Holdings Inc.

The company is a vertically integrated cannabis company led by an industry-leading management team. Jushi is focused on building a multistate portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem.

We seek Safe Harbor.